In vitro- undersøgelser for plasmaproteinbinding indikerer, at abacavir kun i begrænset til moderat omfang (~49%) bindes til humane plasmaproteiner ved terapeutiske koncentrationer.
Plasma protein binding studies in vitro indicate that abacavir binds only low to moderately (~49%) to human plasma proteins at therapeutic concentrations.